title: Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts.
authors.affiliation: Department of Urology, Fujita Health University, School of Medicine, Aichi, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Hoshinaga
authors.forename: R
authors.initials: R
authors.lastname: Shiroki
authors.forename: T
authors.initials: T
authors.lastname: Higuchi
authors.forename: Y
authors.initials: Y
authors.lastname: Horiba
authors.forename: M
authors.initials: M
authors.lastname: Yanaoka
authors.forename: Y
authors.initials: Y
authors.lastname: Naide
mesh_terms: D000293:Adolescent; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use*; D002102:Cadaver; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006085:Graft Survival; D006323:Heart Arrest; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008775:Methylprednisolone / Q000627:therapeutic use*; D008875:Middle Aged; D012263:Ribonucleosides / Q000627:therapeutic use*; D015996:Survival Rate; D014019:Tissue Donors
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine; D008775:Methylprednisolone